BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7646481)

  • 21. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.
    Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F
    Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
    Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
    J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
    Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
    Obulesu M; Rao DM
    Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease: transgenic mouse models and drug assessment.
    Yu P; Oberto G
    Pharmacol Res; 2000 Aug; 42(2):107-14. PubMed ID: 10887038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model mice. Transgenic animals and Alzheimer's research.
    Erickson D
    Sci Am; 1991 Sep; 265(3):34. PubMed ID: 1925493
    [No Abstract]   [Full Text] [Related]  

  • 28. Alzheimer's assault.
    Science; 1992 Feb; 255(5048):1059. PubMed ID: 1546303
    [No Abstract]   [Full Text] [Related]  

  • 29. [Animal model for Alzheimer's disease].
    Takashima A; Chui D
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():240-7. PubMed ID: 15174678
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current state of Alzheimer's disease models: a brief overview].
    Michikawa M
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():233-40. PubMed ID: 22787788
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutant mice: experimental organisms as materialised models in biomedicine.
    Huber L; Keuck LK
    Stud Hist Philos Biol Biomed Sci; 2013 Sep; 44(3):385-91. PubMed ID: 23545252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Species-Specific Genetics on Alzheimer's Mouse Models.
    Hyman B; Tanzi RE
    Neuron; 2019 Feb; 101(3):351-352. PubMed ID: 30731053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moving towards a more realistic concept of what constitutes Alzheimer's disease.
    Hölscher C
    EBioMedicine; 2019 Jan; 39():17-18. PubMed ID: 30579866
    [No Abstract]   [Full Text] [Related]  

  • 34. Toward a better understanding of mouse models of disease.
    Sellers RS; Ward JM
    Vet Pathol; 2012 Jan; 49(1):4. PubMed ID: 22215683
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial Note: Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease.
    PLOS ONE Editors
    PLoS One; 2024; 19(1):e0297928. PubMed ID: 38266031
    [No Abstract]   [Full Text] [Related]  

  • 36. iPSCs to the rescue in Alzheimer's research.
    Choi SH; Tanzi RE
    Cell Stem Cell; 2012 Mar; 10(3):235-6. PubMed ID: 22385650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Of dolphins, humans, other long-lived animals and Alzheimer's disease (Commentary on Vacher et al.).
    Pereyra G; Bovolenta P
    Eur J Neurosci; 2023 Apr; 57(7):1180-1183. PubMed ID: 36861213
    [No Abstract]   [Full Text] [Related]  

  • 38. Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18 (2):239-47, 2019, DOI: 10.1002/pst.1920.
    Edland SD; Raghavan N; Ard MC
    Pharm Stat; 2020 Jul; 19(4):492-493. PubMed ID: 32147862
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to: Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18(2):239-47, 2019, DOI: 10.1002/pst.1920.
    Jin K; Dunn B
    Pharm Stat; 2020 Jul; 19(4):494. PubMed ID: 32147934
    [No Abstract]   [Full Text] [Related]  

  • 40. Correction for Sun et al., Selective filtering defect at the axon initial segment in Alzheimer's disease mouse models.
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34312239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.